Leerink Partners
An Equity Research Associate in the Oncology sector evaluates publicly traded biotechnology companies by analyzing scientific, clinical, commercial, and financial factors. The role involves collaborating with physicians, scientists, and investors to assess investment outcomes while monitoring clinical trials, regulatory updates, and competitive landscapes. This position requires building financial models and supporting investment recommendations based on deep industry knowledge.
Headquarters
Boston, Massachusetts, United States
Company Size
201-500 employees
Founded
1995
Leerink Partners is an investment bank uniquely dedicated to serving innovation-driven and growth-minded healthcare companies.
Leerink Partners Adds Timothy Michel to Trading and Execution Team
Nov 18, 2025
Leerink questions whether BioNTech can thrive without their 'founders' insight' as stock drops
3 days ago
Leerink Partners reiterates Ardelyx stock rating on pipeline progress
21 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Leerink Partners.
26% above the average for this role
He was on the brink amid SVB’s collapse. Now, Jeff Leerink’s firm leads the pack in health care deals.
2 weeks ago
Equity Research Associate – Biotechnology
Piper Sandler & Co.
Director, Investor Relations
Jade Biosciences
Investment Associate
SoftBank Group Corp.
Energy Transition Growth Equity - Investment Intern
Revaia
Investment Associate/Sr. Investment Associate
Pivotal
Msim Tactical Value Acquisitions Associate 2027 Program New York New York United States Of America
Morgan Stanley